ABC294640 (Opaganib)

opaganib · RedHill Biopharma Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ABC294640 (Opaganib), covering 2017-12-07 to 2021-06-18. Get the full timeline:

Most recent: Clinical Trial Update: ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma [Phase 1, Phase 2]